Page last updated: 2024-11-07

19-norandrosterone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

19-norandrosterone: major metabolite of 19-nortestosterone; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9548753
CHEMBL ID3638321
CHEBI ID36412
SCHEMBL ID1220486
MeSH IDM0109984

Synonyms (30)

Synonym
19-norandrosterone
19-noreoiandrosterone
CHEBI:36412
3alpha-hydroxy-5alpha-estran-17-one
LMST02010042
1225-01-0
j109.668k ,
5W4XKU708V ,
SCHEMBL1220486
3-hydroxyestran-17-one #
UOUIARGWRPHDBX-CQZDKXCPSA-N
5.alpha.-estran-3.alpha.-ol-17-one
5.alpha.-estran-17-one, 3.alpha.-hydroxy-
estran-17-one, 3-hydroxy-, (3.alpha.,5.alpha.)-
CHEMBL3638321
estran-17-one, 3-hydroxy-, (3alpha,5alpha)-
5alpha-estran-3alpha-ol-17-one
5alpha-estran-17-one, 3alpha-hydroxy-
unii-5w4xku708v
5a-estran-3a-ol-17-one
(3a,5a)-3-hydroxy-estran-17-one
3a-hydroxy-5a-estran-17-one
h_14_19_norandrosterone
3alpha-hydroxy-5alpha-estran-17-one; 19-norandrosterone; 5alpha-estran-3alpha-ol-17-one
DTXSID10893662
(3r,5s,8r,9r,10s,13s,14s)-3-hydroxy-13-methyl-2,3,4,5,6,7,8,9,10,11,12,14,15,16-tetradecahydro-1h-cyclopenta[a]phenanthren-17-one
5alpha-19-norandrosterone
Q10859482
PD076329
(3as,3br,5as,7r,9as,9br,11as)-7-hydroxy-11a-methyl-hexadecahydro-1h-cyclopenta[a]phenanthren-1-one
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
metaboliteAny intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
17-oxo steroidAny oxo steroid carrying the oxo group at position 17.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (41)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (4.88)18.7374
1990's3 (7.32)18.2507
2000's25 (60.98)29.6817
2010's8 (19.51)24.3611
2020's3 (7.32)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials6 (13.64%)5.53%
Reviews3 (6.82%)6.00%
Case Studies1 (2.27%)4.05%
Observational0 (0.00%)0.25%
Other34 (77.27%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]